Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bio-Rad Laboratories (NY: BIO ) 342.62 +4.93 (+1.46%) Official Closing Price Updated: 4:10 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 267,412 Open 335.68 Bid (Size) 269.74 (1) Ask (Size) 364.00 (1) Prev. Close 337.69 Today's Range 333.26 - 343.97 52wk Range 261.59 - 366.30 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Expert Ratings For Bio-Rad Laboratories October 01, 2024 Via Benzinga S&P 500 Shake-Up: New Entrants Driving Market Momentum September 24, 2024 The quarterly rebalancing of the S&P 500 reflects market capitalization and performance shifts, highlighting growth and challenges in multiple sectors. Via MarketBeat Topics Artificial Intelligence Stocks Exposures Artificial Intelligence US Equities Performance YTD +4.46% +4.46% 1 Month +2.49% +2.49% 3 Month +28.06% +28.06% 6 Month +4.23% +4.23% 1 Year -2.54% -2.54% More News Read More Triple-Witch Says, “Remember Me?” September 20, 2024 Via Talk Markets Palantir Stock Will Join the S&P 500 in September. History Says It Could Soar Afterward. September 13, 2024 Via The Motley Fool Topics Stocks Exposures US Equities Palantir Stock Soars After S&P 500 Inclusion, AI Deal With BP Fuels Additional Gains – What's Next? September 09, 2024 Via Benzinga Topics Artificial Intelligence Stocks Exposures Artificial Intelligence US Equities The Analyst Landscape: 4 Takes On Bio-Rad Laboratories May 08, 2024 Via Benzinga Palantir, Dell Will Join The S&P 500. The AI Stocks Are Jumping. September 06, 2024 Via Investor's Business Daily Topics Artificial Intelligence Stocks Exposures Artificial Intelligence US Equities Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference August 22, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer August 20, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Reports Second-Quarter 2024 Financial Results August 01, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024 July 17, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire S&P 500 Ends First Half Shy Of All-Time Highs. Here Are The Leaders And Laggards — And 5 Stocks That Could Outperform In Next 6 Months June 30, 2024 Via Benzinga Topics Stocks Exposures US Equities OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics June 05, 2024 Via AB Newswire OncoCyte's Innovative Approach: Potential in Precision Diagnostics June 05, 2024 Via TheNewswire.com Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group May 30, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference May 23, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024 May 07, 2024 Via InvestorPlace Bio-Rad Reports First-Quarter 2024 Financial Results May 07, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference May 01, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Announces Life Science Group Management Changes April 26, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire 96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity? April 18, 2024 Via Benzinga Topics Stocks Exposures US Equities Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 April 18, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad’s Chief Operating Officer Andrew Last to Retire April 10, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer March 20, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day February 22, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
